General Clinical Information About Cognitive Disorders in Patients with Cancer

Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standarddose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002; 20: 485-93.

Andreis F, Ferri M, Mazzocchi M, et al. Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study. Support Care Cancer. 2013; 21: 583-90.

Argyriou AA, Assimakopoulos K, Iconomou G, et al. Either called “chemobrain” or “chemofog”, the long-term chemotherapy-induced cognitive decline in cancer survival is real. J Pain Symptom Manage. 2011; 41: 126-39.

Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biological mechanism? A cytokine- immunologic model of cancer symptoms. Cancer 2003; 97: 2919- 25.

Cull A, Hay C, Love SB, et al. What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer. 1996; 74: 1674-9.

Debess J, Riis JO, Engebjerg MC, et al. Cognitive function after adjuvant treatment for early breast cancer: A population-based longitudinal study. Breast Cancer Res Treat. 2010; 121: 91-100.

Donovan KA, Small BJ, Andrykowski MA, et al. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 2005; 104: 2499-507.

Fan HG, Houede-Tchen N, Yi QL, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005; 23: 8025-32.

Gibbons PA. The lived experience of chemobrain in early-stage breast cancer in women 50 and under. J Alzheimers Neurodegener Dis.2019; 5: 20.

Grober S. Resources for treatment of chemotherapy-related cognitive difficulty. Cancer Pract. 2002; 10: 216-8.

Hede K. Chemobrain is real but may need new name. J Natl Cancer Inst. 2008; 100: 162-9.

Jansen CE, Dodd MJ, Miaskowski CA, et al. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psychooncol. 2008;17: 1189-95.

Moore HC. An overview of chemotherapy-related cognitive dysfunction, or “chemobrain”. Oncology (Williston Park). 2014; 28: 797-804.

Munir F, Burrows J, Yarker J, et al. Women’s perceptions of chemotherapy- induced side effects on work ability: A focus group study. J Clin Nurs. 2010; 19: 1362-70.

Olson B, Marks DL. Pretreatment cancer-related cognitive impairment-mechanisms and outlook. Cancers 2019; 119: 1-8.

Schagen SB, Klein M, Reijneveld JC, et al. Monitoring and optimizing cognitive function in cancer patients: Present knowledge and future directions. Eur J Cancer. 2015; 12: 29-40.

Schagen SV, van Dom FS, Muller MJ, et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast cancer. Cancer 1999; 85: 640-50.

Silberforb PM, Philibert D, Levine PM. Psychosocial effects of neoplastic disease:II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry. 1980; 137: 597-601.

Stast K, Segatore M. The phenomenon of chemo brain. Clin J Oncol Nurs. 2005;9: 713-21.

Tanriverdi O, Yavuzsen T, Turhal S, et al. Depression and socio-economical burden are more common in primary caregivers of patients who are not aware of their cancer: TURQUOISE Study by the Palliative Care Working Committee of the Turkish Oncology Group (TOG). Eur J Cancer Care (Engl). 2016; 25: 502-15.

Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 2003; 21: 4175-83.

Tsaveriş N, Kosmos C, Vadioko M, et al. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer.2002; 87: 21-7.

Wefel JS, Lenzi R, Theriault R, et al. “Chemobrain” in breast carcinoma?: a prolongue. Cancer. 2004; 101: 466-75.

Wefel JS, Kesler SR, Noll KR, et al. Clinical characteristics, pathophysiology and management of non-central nervous system cancer related cognitive impairment in adults. CA Cancer J Clin. 2015; 66: 124- 38.

Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol. 2007; 25: 2455-463.

Vardy J, Rourke S, Galica J, et al. Cytokine levels in patients (pts) with localized colorectal cancer (CRC) after surgery and their relationship to fatigue and cognitive function. J Clin Oncol. 2006; 24 (Suupl 18): 3613.

Vardy J, Tannock IF. Cognitive function after chemotherapy in adults with solid tumors. Crit Rev Oncol Hematol. 2007; 63: 183-202.

Von ah D. Cognitive changes associated with cancer and cancer treatment: State of the sciences. Clin J Oncol Nurs. 2015; 1-10.

Zimmer P, Mierau A, Bloch W, et al. Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: A first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leuk Lymphoma. 2015; 56: 437-52.